- Home
- DNLI vs GAB Comparison
DNLI vs GAB Comparison
Compare DNLI & GAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- GAB
- Stock Information
- Founded
- DNLI 2013
- GAB 1986
- Country
- DNLI United States
- GAB United States
- Employees
- DNLI N/A
- GAB N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- GAB Investment Managers
- Sector
- DNLI Health Care
- GAB Finance
- Exchange
- DNLI Nasdaq
- GAB Nasdaq
- Market Cap
- DNLI 2.1B
- GAB 1.8B
- IPO Year
- DNLI 2017
- GAB N/A
- Fundamental
- Price
- DNLI $13.92
- GAB $5.94
- Analyst Decision
- DNLI Strong Buy
- GAB
- Analyst Count
- DNLI 15
- GAB 0
- Target Price
- DNLI $33.85
- GAB N/A
- AVG Volume (30 Days)
- DNLI 1.5M
- GAB 667.8K
- Earning Date
- DNLI 08-04-2025
- GAB 01-01-0001
- Dividend Yield
- DNLI N/A
- GAB 10.91%
- EPS Growth
- DNLI N/A
- GAB N/A
- EPS
- DNLI N/A
- GAB N/A
- Revenue
- DNLI N/A
- GAB N/A
- Revenue This Year
- DNLI N/A
- GAB N/A
- Revenue Next Year
- DNLI $323.34
- GAB N/A
- P/E Ratio
- DNLI N/A
- GAB N/A
- Revenue Growth
- DNLI N/A
- GAB N/A
- 52 Week Low
- DNLI $10.57
- GAB $4.56
- 52 Week High
- DNLI $33.33
- GAB $5.88
- Technical
- Relative Strength Index (RSI)
- DNLI 45.66
- GAB 60.17
- Support Level
- DNLI $13.70
- GAB $5.87
- Resistance Level
- DNLI $14.60
- GAB $5.97
- Average True Range (ATR)
- DNLI 0.65
- GAB 0.06
- MACD
- DNLI -0.06
- GAB 0.00
- Stochastic Oscillator
- DNLI 13.13
- GAB 81.58
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About GAB Gabelli Equity Trust Inc. (The)
Gabelli Equity Trust Inc is a non-diversified closed-end management investment company. Its primary investment objective is the long-term growth of capital with income as a secondary objective. The Fund invests at least its assets in equity securities under normal market conditions. Its equity portfolio includes common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities selected by the Investment Adviser. The company invests in various sectors, of which Food & Beverage, Financial Services, Equipment and Supplies, Entertainment, Consumer Products, Health Care, Diversified Industrial, Business Services, Consumer Services and others.